Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT04503902
Status:
UNKNOWN
Last Update Posted:
2022-11-29
First Post:
2020-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-03
First Submit QC Date:
None
Study First Post Date:
2020-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-28
Last Update Post Date:
2022-11-29
Last Update Post Date Type:
ACTUAL